phenyl acetate has been researched along with Encephalopathy, Toxic in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 11 (45.83) | 24.3611 |
| 2020's | 7 (29.17) | 2.80 |
| Authors | Studies |
|---|---|
| Geohagen, BC; Herr, DW; Huffstickler, M; Jung, GL; LoPachin, RM; McDaniel, KL; Smith, A | 1 |
| Chen, L; Ge, Y; Hu, D; Jia, P; Liu, Y; Ning, H; Yin, Z; Zhang, H | 1 |
| Aristizabal-Henao, JJ; Bowden, JA; Brammer-Robbins, E; El Ahmadie, N; Kroyter, N; Martyniuk, CJ; Nguyen, K; Pena-Delgado, C; Sanchez, CL; Souders, CL; Watkins, JM | 1 |
| Gutiérrez, JM; Lewin, MR; Lomonte, B; Williams, DJ | 1 |
| Fontana Oliveira, IC; Gutiérrez, JM; Lewin, MR; Oshima-Franco, Y | 1 |
| Bickler, PE; Bulfone, TC; Gilliam, J; Gilliam, LL; Gutiérrez, JM; Lewin, MR; Samuel, SP | 1 |
| Bian, J; Chen, J; Gu, J; Liu, X; Liu, Z; Wang, T; Wang, Y; Yang, J; Yuan, Y; Zhao, S; Zou, H | 1 |
| Bale, AS; Makris, SL; Phillips, LJ; Sasso, A; Schlosser, PM; Segal, D; Starkey, C | 1 |
| Ibarra-Barrueta, O; Mayo-Suarez, J; Mora-Atorrasagasti, O; Palacios-Zabalza, I | 1 |
| Bartels, MJ; Flanders, WD; Hunt, DR; Lewis, LS; McGeehin, MA; McMartin, KE; Perala, A; Schier, JG | 1 |
| Banton, M; Borghoff, S; Coder, P; Faber, W; Kirkpatrick, D; Li, A | 1 |
| Demiryas, N; Kalburcu, T; Tüzmen, MN; Yücel, NC | 1 |
| Banton, MI; Bus, JS; Faber, WD; Kirman, CR; McGregor, DB; Pourreau, DB | 1 |
| Ju, J; Lieke, T; Saul, N; Steinberg, CE | 1 |
| Ghosh, A; Hong, H; Hu, M; Lin, JR; Long, Y; Sun, HB; Tang, SS; Wu, F; Zhang, CT | 1 |
| Jeon, BS; Kim, JM | 1 |
| Kalonia, H; Kumar, A; Kumar, P; Nehru, B | 1 |
| Chen, CH; Chen, KL; Chen, SJ; Huang, CF; Hung, DZ; Jinn, TR; Lee, kI; Su, CC; Su, YC; Tang, FC; Tseng, TJ; Yen, CC | 1 |
| BESSMAN, SP; LEIKIN, S; RUBIN, M | 1 |
| Butt, MT; Jortner, BS; Levine, AB; McDaniel, KL; Moser, VC; Phillips, PM; Sills, RC | 1 |
| Akesson, B; Bergendorf, U; Karlson, B; Orbaek, P; Osterberg, K; Seger, L | 1 |
| Alao, AO; Dewan, MJ | 1 |
| Mawer, GE; Sander, JW; Wong, IC | 1 |
2 review(s) available for phenyl acetate and Encephalopathy, Toxic
| Article | Year |
|---|---|
Issues in assessing the health risks of n-butanol.
Topics: 1-Butanol; Acetates; Animals; Embryonic Development; Environmental Exposure; Environmental Pollutants; Female; Humans; Nervous System; Neurotoxicity Syndromes; Pregnancy; Prenatal Exposure Delayed Effects; Risk Assessment; Toxicity Tests; Toxicokinetics | 2020 |
Human health screening level risk assessments of tertiary-butyl acetate (TBAC): calculated acute and chronic reference concentration (RfC) and Hazard Quotient (HQ) values based on toxicity and exposure scenario evaluations.
Topics: Acetates; Animals; Biotransformation; Disease Models, Animal; Dose-Response Relationship, Drug; Environmental Exposure; Hazardous Substances; Humans; Neurotoxicity Syndromes; No-Observed-Adverse-Effect Level; Risk Assessment; Toxicity Tests, Acute; Toxicity Tests, Chronic | 2015 |
1 trial(s) available for phenyl acetate and Encephalopathy, Toxic
| Article | Year |
|---|---|
Psychological test performance during experimental challenge to toluene and n-butyl acetate in cases of solvent-induced toxic encephalopathy.
Topics: Acetates; Adult; Aged; Analysis of Variance; Attention; Cognition; Humans; Male; Middle Aged; Multiple Chemical Sensitivity; Neuropsychological Tests; Neurotoxicity Syndromes; Olfaction Disorders; Reaction Time; Solvents; Toluene | 2000 |
21 other study(ies) available for phenyl acetate and Encephalopathy, Toxic
| Article | Year |
|---|---|
In vivo neurophysiological assessment of in silico predictions of neurotoxicity: Citronellal, 3,4-dichloro-1-butene, and benzyl bromoacetate.
Topics: Acetates; Action Potentials; Acyclic Monoterpenes; Aldehydes; Animals; Hydrocarbons, Chlorinated; Male; Neural Conduction; Neurotoxicity Syndromes; Peripheral Nerves; Rats; Rats, Long-Evans | 2022 |
Acute lead acetate induces neurotoxicity through decreased synaptic plasticity-related protein expression and disordered dendritic formation in nerve cells.
Topics: Acetates; Animals; Female; Hippocampus; Humans; Lead; Mice; Neuronal Plasticity; Neurons; Neurotoxicity Syndromes; Synapses | 2022 |
Neurotoxicity assessment of QoI strobilurin fungicides azoxystrobin and trifloxystrobin in human SH-SY5Y neuroblastoma cells: Insights from lipidomics and mitochondrial bioenergetics.
Topics: Acetates; Adenosine Triphosphate; Cell Line, Tumor; Ethers; Fungicides, Industrial; Humans; Imines; Lipidomics; Membrane Potential, Mitochondrial; Neuroblastoma; Neurotoxicity Syndromes; Phosphatidylethanolamines; Pyrimidines; Strobilurins; Triglycerides | 2022 |
Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms.
Topics: Acetates; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Indoles; Keto Acids; Lethal Dose 50; Mice; Neurotoxicity Syndromes; Phospholipase A2 Inhibitors; Phospholipases A2; Snake Bites; Snake Venoms; Survival Analysis; Time Factors | 2020 |
In brief: Neuropsychiatric events with montelukast.
Topics: Acetates; Anti-Asthmatic Agents; Cyclopropanes; Humans; Leukotriene Antagonists; Neurotoxicity Syndromes; Quinolines; Suicide; Sulfides | 2020 |
Varespladib (LY315920) inhibits neuromuscular blockade induced by Oxyuranus scutellatus venom in a nerve-muscle preparation.
Topics: Acetates; Antivenins; Elapid Venoms; Indoles; Keto Acids; Neuromuscular Blockade; Neuromuscular Diseases; Neuromuscular Junction; Neurotoxicity Syndromes; Neurotoxins; Snake Bites | 2020 |
Delayed LY333013 (Oral) and LY315920 (Intravenous) Reverse Severe Neurotoxicity and Rescue Juvenile Pigs from Lethal Doses of
Topics: Acetates; Administration, Intravenous; Administration, Oral; Animals; Antivenins; Blood Coagulation; Coral Snakes; Elapid Venoms; Female; Indoles; Keto Acids; Neuroprotective Agents; Neurotoxicity Syndromes; Phospholipase A2 Inhibitors; Snake Bites; Swine | 2018 |
Alpha-lipoic acid protects against cadmium-induced neuronal injury by inhibiting the endoplasmic reticulum stress eIF2α-ATF4 pathway in rat cortical neurons in vitro and in vivo.
Topics: Acetates; Activating Transcription Factor 4; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cadmium; Cells, Cultured; Cerebral Cortex; Cytoprotection; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Female; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Rats, Sprague-Dawley; Signal Transduction; Thioctic Acid | 2019 |
Effect of concomitant use of montelukast and efavirenz on neuropsychiatric adverse events.
Topics: Acetates; Adult; Alkynes; Anti-Asthmatic Agents; Anti-HIV Agents; Asthma; Benzoxazines; Cyclopropanes; Drug Interactions; Female; HIV Infections; Humans; Neurotoxicity Syndromes; Quinolines; Sulfides | 2014 |
Characterizing concentrations of diethylene glycol and suspected metabolites in human serum, urine, and cerebrospinal fluid samples from the Panama DEG mass poisoning.
Topics: Acetates; Biomarkers; Case-Control Studies; Centers for Disease Control and Prevention, U.S.; Ethylene Glycols; Female; Fomepizole; Gas Chromatography-Mass Spectrometry; Glycolates; Humans; Kidney; Logistic Models; Male; Neurotoxicity Syndromes; Panama; Poisoning; Pyrazoles; Renal Dialysis; Specimen Handling; United States | 2013 |
Subchronic, reproductive, and maternal toxicity studies with tertiary butyl acetate (TBAC).
Topics: Acetates; Adrenal Glands; Alpha-Globulins; Animals; Female; Kidney; Liver; Male; Maternal-Fetal Exchange; Mice; Motor Activity; Neurotoxicity Syndromes; Organ Size; Pregnancy; Rats; Reproduction; Solvents; Thyroxine; Toxicity Tests, Subchronic | 2014 |
Effects of curcumin and tannic acid on the aluminum- and lead-induced oxidative neurotoxicity and alterations in NMDA receptors.
Topics: Acetates; Acetylcholinesterase; Animals; Antioxidants; Brain; Catalase; Curcumin; Disease Models, Animal; Glutathione; Glutathione Peroxidase; GPI-Linked Proteins; Lead Poisoning, Nervous System; Lipid Peroxidation; Male; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Organometallic Compounds; Oxidative Stress; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Superoxide Dismutase; Tannins; Up-Regulation | 2015 |
Natural Marine and Synthetic Xenobiotics Get on Nematode's Nerves: Neuro-Stimulating and Neurotoxic Findings in Caenorhabditis elegans.
Topics: Acetates; Animals; Biological Products; Bivalvia; Caenorhabditis elegans; Environment; Geologic Sediments; Nematoda; Nervous System; Neurotoxicity Syndromes; Polybrominated Biphenyls; Xenobiotics | 2015 |
Montelukast ameliorates streptozotocin-induced cognitive impairment and neurotoxicity in mice.
Topics: Acetates; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cognitive Dysfunction; Cyclopropanes; Disease Models, Animal; Hippocampus; Interleukin-1beta; Male; Maze Learning; Mice; Mice, Inbred ICR; Neurotoxicity Syndromes; Proto-Oncogene Proteins c-bcl-2; Quinolines; Receptors, Leukotriene; RNA, Messenger; Streptozocin; Sulfides; Tumor Necrosis Factor-alpha | 2016 |
Survivors from beta-fluoroethyl acetate poisoning show a selective cerebellar syndrome.
Topics: Acetates; Adult; Brain; Cerebellar Diseases; Cerebellum; Coma; Female; Follow-Up Studies; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurotoxicity Syndromes; Rodenticides; Suicide, Attempted; Survivors; Tomography, X-Ray Computed | 2009 |
Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats.
Topics: Acetates; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Brain; Brain Chemistry; Catalase; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Gene Expression Regulation; Lipid Peroxidation; Male; Malonates; Mitochondria; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Nitrites; Quinolines; Quinolinic Acid; Rats; Rats, Wistar; Sulfides; Superoxide Dismutase; Tetrazolium Salts; Thiazoles; Tumor Necrosis Factor-alpha | 2010 |
Chloroacetic acid induced neuronal cells death through oxidative stress-mediated p38-MAPK activation pathway regulated mitochondria-dependent apoptotic signals.
Topics: Acetates; Animals; Anthracenes; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Glutathione; Imidazoles; Mice; Mitochondria; Neuroblastoma; Neurons; Neurotoxicity Syndromes; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines | 2013 |
The treatment of lead encephalopathy; a method for the removal of lead during the acute stage.
Topics: Acetates; Lead Poisoning; Neurotoxicity Syndromes | 1954 |
Neurotoxicity produced by dibromoacetic acid in drinking water of rats.
Topics: Acetates; Administration, Oral; Alopecia; Animals; Behavior, Animal; Body Temperature; Disinfectants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Male; Motor Activity; Nerve Degeneration; Neurotoxicity Syndromes; Rats; Rats, Inbred F344; Sex Factors; Spinal Nerves; Time Factors; Water Pollution, Chemical; Water Supply; Weight Gain | 2004 |
Evaluating the tolerability of the newer mood stabilizers.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Central Nervous System Diseases; Cyclohexanecarboxylic Acids; Drug Information Services; Fructose; Gabapentin; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Incidence; Lamotrigine; Mental Disorders; Neurotoxicity Syndromes; Topiramate; Triazines; Valproic Acid | 2001 |
Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom.
Topics: Acetates; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Amines; Anticonvulsants; Child; Cyclohexanecarboxylic Acids; Death, Sudden; Drug Eruptions; Epilepsy; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Incidence; Lamotrigine; Male; Middle Aged; Neurotoxicity Syndromes; Pharmacoepidemiology; Product Surveillance, Postmarketing; Triazines; United Kingdom; Vigabatrin | 2001 |